Clinical Trial Update: Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant nab-paclitaxel plus cisplatin for stage II-III esophageal squamous cell carcinoma has completed. The study was conducted at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Platinol (cisplatin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED